DE:78Q Stock Latest News
Company AnnouncementsMediobanca Buys 16,754 Philogen Shares in October3h ago
Company AnnouncementsPhilogen Expands Treasury Stock Through Ongoing Share Buyback1w ago
Company AnnouncementsPhilogen Continues Share Buyback, Accumulating Nearly 1% of Capital2w ago
Company AnnouncementsPhilogen Expands Treasury Position Under Ongoing Share Buyback3w ago
Company AnnouncementsMediobanca Steps Up Trading Activity in Listed Shares of Philogen4w ago
Company AnnouncementsPhilogen Updates on Modest Progress in Ongoing Share Buyback Program1M ago
Company AnnouncementsPhilogen Reports Mediobanca Share Purchase on Italian Market2M ago
Company AnnouncementsMediobanca Reports Purchase of Philogen Shares on Italian Market3M ago
Company AnnouncementsPhilogen Updates Share Buyback as Treasury Stake Nears 0.9% of Capital3M ago
Company AnnouncementsPhilogen resubmits strengthened EMA application for melanoma drug Nidlegy3M ago
Company AnnouncementsPhilogen Publishes Shareholders’ Meeting Minutes and Highlights Targeted Cancer-Drug Focus5M ago
Company AnnouncementsPhilogen Maintains Strong Cash Position as Oncology Pipeline Advances on Schedule5M ago
Company AnnouncementsPhilogen Approves 2025 Results, €0.70 Dividend and New Share Buyback Mandate6M ago
Company AnnouncementsPhilogen Continues Euronext Milan Share Buyback, Nears 0.9% Treasury Stake6M ago
Company AnnouncementsPhilogen Details Voting Rights Structure Ahead of April 29 Shareholders’ Meeting6M ago
Company AnnouncementsPhilogen Adds to Treasury Stock as Biotech Group Advances Targeted Cancer Strategy6M ago
Company AnnouncementsPhilogen Expands Treasury Stock Position as Share Buyback Programme Progresses6M agoCompany AnnouncementsPhilogen Publishes 2025 Financial and Governance Reports Ahead of April 2026 Shareholders’ Meeting6M ago



